HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Report
- Report Number
- 2025587-2017-01578
- Event Type
- Injury
- Date Received
- September 11, 2017
- Date of Event
- August 12, 2015
- Report Date
- August 21, 2017
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- LWR
- PMA / PMN Number
- P980043
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AR, US
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: SHINKAWA T ET AL. THE MIDTERM OUTCOMES OF BIOPROSTHETIC PULMONARY VALVE REPLACEMENT IN CHILDREN. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY. 2015. 27(3):310-8 DOI: 10.1053/J.SEMTCVS.2015.07.010 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING A RETROSPECTIVE REVIEW OF OUTCOMES OF BIOPROSTHETIC PULMONARY VALVE REPLACEMENT IN CHILDREN. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 1992 AND 2013. THE STUDY POPULATION INCLUDED 123 PATIENTS (PREDOMINANTLY MALE; MEAN AGE 13 YEARS), 15 OF WHICH WERE IMPLANTED WITH MEDTRONIC HANCOCK II (SERIAL NUMBERS NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: MODERATE INSUFFICIENCY, ELEVATED PEAK GRADIENT, ENDOCARDITIS, AND STENOSIS REQUIRING REOPERATION OR CATHETER-BASED INTERVENTION. MULTIPLE MANUFACTURERS WERE NOTED IN THE LITERATURE; BASED ON THE AVAILABLE INFORMATION, A DIRECT CORRELATION COULD NOT BE MADE BETWEEN THE OBSERVED ADVERSE EVENTS AND MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 636324 | HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE | HEART-VALVE, NON-ALLOGRAFT TISSUE | LWR | MEDTRONIC HEART VALVES DIVISION | T505 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 13 YR | Required Intervention |